Receptor activator of nuclear factor‐kappa B ligand induces osteoclast formation in RAW 264.7 macrophage cells via augmented production of macrophage–colony‐stimulating factor |
| |
Authors: | Shamima Islam Ferdaus Hassan Gantsetseg Tumurkhuu Jargalsaikhan Dagvadorj Naoki Koide Yoshikazu Naiki Tomoaki Yoshida Takashi Yokochi |
| |
Institution: | Department of Microbiology and Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan |
| |
Abstract: | RAW 264.7 macrophage cells differentiate into osteoclast‐like cells in the presence of RANKL. Participation of M‐CSF in RANKL‐induced osteoclast formation of RAW 264.7 cells was examined. TRAP‐positive osteoclast‐like cells appeared in RAW 264.7 cells cultured in the presence of RANKL. RANKL‐induced osteoclast formation was markedly inhibited by anti‐M‐CSF antibody. RANKL augmented M‐CSF mRNA expression and M‐CSF production in RAW 264.7 cells. Further, anti‐M‐CSF antibody inhibited the expression of RANK, c‐fms, c‐fos and TRAP mRNA in RANKL‐stimulated RAW 264.7 cells. However, anti‐M‐CSF antibody did not affect the expression of DC‐STAMP in the stimulated cells. Therefore, RANKL was suggested to induce osteoclast formation in RAW 264.7 cells via augmented production of M‐CSF. The putative role of M‐CSF in RANKL‐induced osteoclast formation of RAW 264.7 cells is discussed. |
| |
Keywords: | macrophage– colony‐stimulating factor (M‐CSF) osteoclast RAW 264 7 cells receptor activator of nuclear factor‐κ B ligand (RANKL) tartrate‐resistant acid phosphatase (TRAP) |
|
|